US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Metsera Inc.

19.51

-0.0600-0.31%

Post-market: 19.20-0.3100-1.59%18:15 EDT

Volume:1.73M

Turnover:36.44M

Market Cap:2.05B

PE:-1.35

High:22.57

Open:19.21

Low:18.64

Close:19.57

Loading ...

Overview Company News Filings

Cantor Fitzgerald Initiates Metsera at Overweight

MT Newswires Live

Metsera Inc : Bofa Global Research Initiates Coverage With Buy Rating; Price Objective $38

THOMSON REUTERS

Analysts Offer Insights on Technology Companies: Palo Alto Networks (PANW), Metsera, Inc. (MTSR) and Five9 (FIVN)

Metsera, Inc.: Buy Rating Affirmed Due to Innovative Obesity Market Approach and Strong Growth Catalysts

Metsera, Inc.: A Promising Buy in the Obesity Market with Potential for Significant Returns

Metsera initiated with a Buy at Guggenheim

Metsera initiated as Early-Stage Biotech at Goldman Sachs

Metsera (MTSR): Among Stocks Insiders Spent The Most Money On Recently

Metsera Closes Initial Public Offering

MT Newswires Live

Metsera Shares Rise Sharply in Nasdaq Debut

MT Newswires Live

Metsera hits $2.7 bln valuation as shares surge 42% in Nasdaq debut

Weight-loss drug developer Metsera valued at $2.68 bln as shares jumped in market debut

Stock Track | Metsera Inc. Soars 41.67% on Nasdaq Debut After Successful $275 Million IPO

Oil company Infinity Natural Resources debuts IPO amid deregulation push

Metsera Prices $275 Million IPO

MT Newswires Live

BRIEF-Metsera Prices IPO Of 15.28 Mln Shares At $18.00 Per Share

Metsera Announces Pricing of Initial Public Offering

THOMSON REUTERS

Metsera Inc - Expects Gross Proceeds of Approximately $275 Million From IPO

THOMSON REUTERS

Metsera Inc - Prices IPO of 15.28 Mln Shares at $18.00 per Share

THOMSON REUTERS

Metsera Announces Pricing of Initial Public Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MTSR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":19.51,"timestamp":1745265600000,"preClose":19.57,"halted":0,"volume":1733503,"hourTrading":{"tag":"盘后","latestPrice":19.2,"preClose":19.51,"latestTime":"18:15 EDT","volume":8776,"amount":169832.80096,"timestamp":1745273753685},"delay":0,"floatShares":59968852,"shares":105050219,"eps":-14.490661,"marketStatus":"Post-Mkt","change":-0.06,"latestTime":"04-21 18:18:28 EDT","open":19.21,"high":22.57,"low":18.6401,"amount":36436679.841312,"amplitude":0.200812,"askPrice":22.02,"askSize":100,"bidPrice":19,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-14.490661,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":19.57,"preHourTrading":{"tag":"盘前","latestPrice":19.3,"preClose":19.57,"latestTime":"09:28 EDT","volume":2458,"amount":48090.912564,"timestamp":1745242083000},"postHourTrading":{"tag":"盘后","latestPrice":19.2,"preClose":19.51,"latestTime":"18:15 EDT","volume":8776,"amount":169832.80096,"timestamp":1745273753685},"volumeRatio":1.109617},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","floatShares":59968852,"roa":"-27.09%","roe":"-108.40%","lyrEps":-14.490661,"volumeRatio":1.109617,"shares":105050219,"dividePrice":0,"high":22.57,"amplitude":0.200812,"preClose":19.57,"low":18.6401,"week52Low":12.3,"pbRate":"-8.08","week52High":32.8082,"institutionHeld":0,"latestPrice":19.51,"committee":-0.818182,"eps":-14.490661,"divideRate":0,"volume":1733503,"delay":0,"ttmEps":-14.490661,"open":19.21,"prevYearClose":18,"prevWeekClose":19.57,"prevMonthClose":27.22,"prevQuarterClose":27.22,"fiveDayClose":14,"twentyDayClose":28.02,"sixtyDayClose":18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTSR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514632067","title":"Cantor Fitzgerald Initiates Metsera at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2514632067","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514632067?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:23","pubTimestamp":1740482634,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald Initiates Metsera at Overweight","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTSR"],"gpt_icon":0},{"id":"2514062891","title":"Metsera Inc : Bofa Global Research Initiates Coverage With Buy Rating; Price Objective $38","url":"https://stock-news.laohu8.com/highlight/detail?id=2514062891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514062891?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:03","pubTimestamp":1740481437,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG027:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MTSR"],"gpt_icon":0},{"id":"2514062676","title":"Analysts Offer Insights on Technology Companies: Palo Alto Networks (PANW), Metsera, Inc. (MTSR) and Five9 (FIVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514062676","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514062676?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:00","pubTimestamp":1740481233,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Palo Alto Networks (PANW – Research Report), Metsera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-palo-alto-networks-panw-metsera-inc-mtsr-and-five9-fivn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-palo-alto-networks-panw-metsera-inc-mtsr-and-five9-fivn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU1804176565.USD","LU1169589451.USD","LU2125909759.SGD","LU2265009873.SGD","BK4598","IE00BMPRXR70.SGD","IE00B19Z9505.USD","LU1720051108.HKD","IE00B19Z8W00.USD","LU1861220033.SGD","LU1169590202.USD","LU2125909916.SGD","LU2023250504.SGD","PANW","BK4023","MTSR","BK4560","LU1917777945.USD","BK4532","IE00B19Z8X17.USD","LU1989764748.USD","LU1974910355.USD","BK4588","BK4097","IE00BMPRXN33.USD","LU0348723411.USD","LU1548497426.USD","BK4585","LU0234570918.USD","BK4581","FIVN","LU1923622291.USD","LU1989764664.SGD","LU1720051017.SGD","LU2286300806.USD","LU2023250843.SGD","LU2106854487.HKD","LU1861215975.USD","LU2357305700.SGD","BK4550"],"gpt_icon":0},{"id":"2514062618","title":"Metsera, Inc.: Buy Rating Affirmed Due to Innovative Obesity Market Approach and Strong Growth Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2514062618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514062618?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:00","pubTimestamp":1740481213,"startTime":"0","endTime":"0","summary":"Metsera, Inc. (MTSR) has received a new Buy rating, initiated by Bank of America Securities analyst, Tim Anderson. Tim Anderson has given his Buy r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/metsera-inc-buy-rating-affirmed-due-to-innovative-obesity-market-approach-and-strong-growth-catalysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/metsera-inc-buy-rating-affirmed-due-to-innovative-obesity-market-approach-and-strong-growth-catalysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTSR"],"gpt_icon":0},{"id":"2514406902","title":"Metsera, Inc.: A Promising Buy in the Obesity Market with Potential for Significant Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2514406902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514406902?lang=en_us&edition=fundamental","pubTime":"2025-02-25 18:16","pubTimestamp":1740478568,"startTime":"0","endTime":"0","summary":"Seamus Fernandez, an analyst from Guggenheim, has initiated a new Buy rating on Metsera, Inc. (MTSR). Seamus Fernandez has given his Buy rating due...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/metsera-inc-a-promising-buy-in-the-obesity-market-with-potential-for-significant-returns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/metsera-inc-a-promising-buy-in-the-obesity-market-with-potential-for-significant-returns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"2514048069","title":"Metsera initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2514048069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514048069?lang=en_us&edition=fundamental","pubTime":"2025-02-25 18:15","pubTimestamp":1740478532,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of Metsera (MTSR) with a Buy rating and $56 price target The firm sees a “highly promising multi-billion opportunity”...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metsera-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metsera-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"2514506511","title":"Metsera initiated as Early-Stage Biotech at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2514506511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514506511?lang=en_us&edition=fundamental","pubTime":"2025-02-25 17:31","pubTimestamp":1740475888,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Chris Shibutani initiated coverage of Metsera (MTSR) as an Early-Stage Biotech. Metsera is clinical-stage biopharmaceutical c...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metsera-initiated-as-early-stage-biotech-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metsera-initiated-as-early-stage-biotech-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4516","LU2237443465.HKD","IE0004086264.USD","BK4588","LU1868836591.USD","LU2237443382.USD","LU1868836914.USD","LU2471134796.USD","LU1868836757.USD","BK4504","LU1868837136.USD","LU2237443549.SGD","LU2237443978.SGD","MTSR","LU2237438978.USD","LU2750360997.AUD","LU2750360641.GBP","IE00B19Z3581.USD","LU2471134523.USD","SSI","BK4552","IE0002270589.USD","IE00B19Z3B42.SGD","LU1668664300.SGD","BK4139","BK4533","LU2237443622.USD","BK4127","IE00BSNM7G36.USD","LU0061475181.USD","LU2471134879.HKD","LU2471134952.CNY","LU0106831901.USD","IE00BFXG1179.USD","LU1791807156.HKD","LU1868837300.USD","IE0034235188.USD","BK4550","LU2237443895.HKD","LU0096364046.USD","IE0004091025.USD","BK4585"],"gpt_icon":0},{"id":"2512943679","title":"Metsera (MTSR): Among Stocks Insiders Spent The Most Money On Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2512943679","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512943679?lang=en_us&edition=fundamental","pubTime":"2025-02-20 03:50","pubTimestamp":1739994654,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Insiders Spent The Most Money On Recently. In this article, we are going to take a look at where Metsera  stands against other stocks insiders spent the most money on recently.As the broader market continues to rise this year, we thought it would be interesting to highlight some stocks that have seen significant insider buying recently. Insiders—such as executives and directors—often have valuable insights into a company’s strategy, plans, and future initiatives. For instance, when a CEO or CFO invests their own money to purchase company shares, it can be seen as a strong vote of confidence in the company’s prospects. When an insider makes a substantial financial commitment, it often signals an even higher level of confidence in the company’s future performance.What are some of the stocks that have seen the most insider investment recently?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/metsera-mtsr-among-stocks-insiders-195054961.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"2509259250","title":"Metsera Closes Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2509259250","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509259250?lang=en_us&edition=fundamental","pubTime":"2025-02-06 06:42","pubTimestamp":1738795373,"startTime":"0","endTime":"0","summary":"Metsera (MTSR) said late Wednesday it has raised about $316.2 million from the initial public offering of its shares, including the exercise of over-allotment option.Shares of the clinical-stage biotechnology company started trading on Nasdaq Jan. 31.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTSR","NQmain"],"gpt_icon":0},{"id":"2508387995","title":"Metsera Shares Rise Sharply in Nasdaq Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2508387995","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508387995?lang=en_us&edition=fundamental","pubTime":"2025-02-01 02:02","pubTimestamp":1738346529,"startTime":"0","endTime":"0","summary":"Metsera  shares rose sharply in their trading debut on Nasdag Friday after the company priced its initial public offering of almost 15.3 million shares at $18 per share.The stock was up about 45% at $26.10 in recent trading after opening at $25.50.The clinical-stage biotechnology company granted its underwriters a 30-day option to buy up to roughly 2.3 million additional shares. It expects to close the offering Monday.BofA Securities, Goldman Sachs, Evercore ISI, Guggenheim Securities and Cantor are joint bookrunners for the offering.Price: 26.31, Change: +8.31, Percent Change: +46.17","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TSYW.SI","QID","NDAQ","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","LU2237443465.HKD","PSQ","MNQmain",".IXIC","IE00BSNM7G36.USD","LU2237443978.SGD","IE00B19Z3B42.SGD","IE00B3QW5Z07.USD","LU2237443549.SGD","IE00B19Z3581.USD","BK4504","IE00BFXG1179.USD","BK4533","LU2237438978.USD","USJW.SI","MTSR","LU1791807156.HKD","BK4585","SQQQ","TQQQ","USAW.SI","BK4127","IE00BKPKM429.USD","IE0034235188.USD","IE0002270589.USD","QLD","LU1668664300.SGD","IE00BGHQF748.EUR","BK4516","LU2210149790.SGD","LU2237443895.HKD","LU0106831901.USD","LU2237443382.USD","BK4550","NVIW.SI","NQmain","LU2237443622.USD","BK4112","LU2210150020.SGD","BK4552","IE0004086264.USD","IE0004091025.USD"],"gpt_icon":1},{"id":"2508993025","title":"Metsera hits $2.7 bln valuation as shares surge 42% in Nasdaq debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2508993025","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508993025?lang=en_us&edition=fundamental","pubTime":"2025-02-01 02:02","pubTimestamp":1738346526,"startTime":"0","endTime":"0","summary":"UPDATE 3-Metsera hits $2.7 bln valuation as shares surge 42% in Nasdaq debutAdd biotech firms details in paragraph 5, analyst comment in paragraphs 6 and 7By Prakhar Srivastava. Jan 31  - Shares of weight-loss drug developer Metsera MTSR.O surged nearly 42% in a strong Nasdaq debut on Friday, valuing the ARCH Venture Partners-backed biotech firm at $2.68 billion.The strong market debut of the New York City-based biotech company highlights the growing investor interest in companies developing innovative weight-loss treatments.Shares of the company opened at $25.5 apiece, compared with the initial public offering price of $18.Some expects forecast that the global weight-loss drug market could be valued at $150 billion by the early 2030s.Last year, biotech firms such as BioAge Labs BIOA.O and MBX Biosciences MBX.O were well received on their debuts, but have lost ground to trade much lower than their IPO price, as of Jan. 31.\"Stock prices in this space are highly sensitive to breakthrough","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nL3N3OR1CP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR"],"gpt_icon":0},{"id":"2508993350","title":"Weight-loss drug developer Metsera valued at $2.68 bln as shares jumped in market debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2508993350","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508993350?lang=en_us&edition=fundamental","pubTime":"2025-02-01 01:39","pubTimestamp":1738345187,"startTime":"0","endTime":"0","summary":"Weight-loss drug developer Metsera valued at $2.68 bln as shares jumped in market debutJan 31 (Reuters) - Shares of weight-loss drug developer Metsera MTSR.O jumped nearly 42% in a strong Nasdaq debut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nL3N3OR1C8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR"],"gpt_icon":0},{"id":"1136356581","title":"Stock Track | Metsera Inc. Soars 41.67% on Nasdaq Debut After Successful $275 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1136356581","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136356581?lang=en_us&edition=fundamental","pubTime":"2025-02-01 01:36","pubTimestamp":1738344982,"startTime":"0","endTime":"0","summary":"Metsera Inc., a biotechnology company developing an obesity drug called MET-097i, saw its shares surge 41.67% on its first day of trading on the Nasdaq Global Select Market.The stock's stellar debut performance followed Metsera's successful pricing of its initial public offering on Thursday. The company sold 15.3 million shares at $18 apiece, raising $275 million in gross proceeds.Metsera's strong first-day gains reflect robust investor demand for the newly public biotech firm. The IPO was price","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Metsera Inc. Soars 41.67% on Nasdaq Debut After Successful $275 Million IPO","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["MTSR"],"gpt_icon":0},{"id":"2507961888","title":"Oil company Infinity Natural Resources debuts IPO amid deregulation push","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961888","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507961888?lang=en_us&edition=fundamental","pubTime":"2025-01-31 23:20","pubTimestamp":1738336800,"startTime":"0","endTime":"0","summary":"Company prices above midrange as the largest of a batch of initial public offerings on Friday. Infinity Natural Resources Inc. priced its initial public offering above the midpoint of its range in a sign of a strong stock-market debut for the oil and gas producer, which operates in Ohio and Pennsylvania.The IPO comes amid a deregulatory push in the energy sector by President Donald Trump, who repeated the \"drill, baby, drill\" slogan in his inaugural address.Earlier this week, Sean Duffy, the newly sworn-in Transportation secretary, ordered a review of fuel-economy standards laid out by the Biden administration.Infinity Natural Resources  priced 13.25 million shares at $20 for proceeds of $265 million. The IPO priced toward the upper end of its range of $18 to $21 in a sign of healthy demand.Infinity Natural Resources is the largest of a handful of IPOs on Friday.Maze Therapeutics Inc.  priced 8.75 million shares at $16 a share for proceeds of $140 million. The stock priced at the midpo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR","BBNX","MAZE","INR"],"gpt_icon":0},{"id":"2507937833","title":"Metsera Prices $275 Million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2507937833","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507937833?lang=en_us&edition=fundamental","pubTime":"2025-01-31 16:47","pubTimestamp":1738313245,"startTime":"0","endTime":"0","summary":"Metsera  said late Thursday it priced its initial public offering of about 15.3 million common shares at $18 per share for expected gross proceeds of $275 million.The biotechnology company granted the underwriters a 30-day option to purchase up to roughly 2.3 million additional shares.Closing of the offering is expected to occur on Feb. 3, subject to customary conditions.The shares are expected to begin trading on the Nasdaq Global Select Market on Friday under the ticker \"MTSR.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTSR"],"gpt_icon":0},{"id":"2507698541","title":"BRIEF-Metsera Prices IPO Of 15.28 Mln Shares At $18.00 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2507698541","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507698541?lang=en_us&edition=fundamental","pubTime":"2025-01-31 10:08","pubTimestamp":1738289319,"startTime":"0","endTime":"0","summary":"BRIEF-Metsera Prices IPO Of 15.28 Mln Shares At $18.00 Per ShareJan 30 (Reuters) - Metsera Inc MTSR.O:METSERA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERINGMETSERA INC - PRICES IPO OF 15.28 MILLION SHAR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nTUA98LV9Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR"],"gpt_icon":0},{"id":"2507730602","title":"Metsera Announces Pricing of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2507730602","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507730602?lang=en_us&edition=fundamental","pubTime":"2025-01-31 07:53","pubTimestamp":1738281191,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nTUA98LV9Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTSR"],"gpt_icon":0},{"id":"2507602067","title":"Metsera Inc - Expects Gross Proceeds of Approximately $275 Million From IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2507602067","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507602067?lang=en_us&edition=fundamental","pubTime":"2025-01-31 07:53","pubTimestamp":1738281191,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nTUA98LV9Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTSR"],"gpt_icon":0},{"id":"2507260206","title":"Metsera Inc - Prices IPO of 15.28 Mln Shares at $18.00 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2507260206","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507260206?lang=en_us&edition=fundamental","pubTime":"2025-01-31 07:53","pubTimestamp":1738281191,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nTUA98LV9Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MTSR"],"gpt_icon":0},{"id":"2507064602","title":"Metsera Announces Pricing of Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2507064602","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507064602?lang=en_us&edition=fundamental","pubTime":"2025-01-31 07:53","pubTimestamp":1738281180,"startTime":"0","endTime":"0","summary":"NEW YORK, Jan.  30, 2025  (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormon","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/30/3018515/0/en/Metsera-Announces-Pricing-of-Initial-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU1668664300.SGD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU2237438978.USD","LU2237443549.SGD","BK4585","BK4588","IE00BFXG1179.USD","LU2237443978.SGD","IE0004091025.USD","LU2237443895.HKD","MTSR","IE0004086264.USD","BK4552","IE0034235188.USD","BK4533","LU0106831901.USD","LU2237443382.USD","LU2237443465.HKD","IE00B19Z3581.USD","LU2237443622.USD","IE0002270589.USD","BK4127","BK4516","BK4550","LU1791807156.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTSR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-26","symbol":"MTSR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-3.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTSR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTSR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTSR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTSR","date":"2025-04-17","current":-8.815846,"percent":0.857143,"low":-55.8522,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"high":-6.570442,"avg":-15.990528,"sd":6.909743,"marketCap":1843631343},"quantilePoints":[{"date":"2025-02-07","current":-17.973411,"twenty":-17.939327,"median":-17.8882,"eighty":-17.837073,"marketCap":3042628924},{"date":"2025-02-14","current":-18.277736,"twenty":-18.639274,"median":-18.277736,"eighty":-17.958804,"marketCap":3094146515},{"date":"2025-02-21","current":-19.257661,"twenty":-19.263748,"median":-18.612493,"eighty":-17.973411,"marketCap":3260033158},{"date":"2025-02-28","current":-15.222317,"twenty":-19.263748,"median":-18.292952,"eighty":-17.802989,"marketCap":2576909901},{"date":"2025-03-07","current":-16.749262,"twenty":-19.257661,"median":-17.973411,"eighty":-16.634383,"marketCap":2835398748},{"date":"2025-03-14","current":-15.094245,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":2555229332},{"date":"2025-03-21","current":-17.309229,"twenty":-18.72205,"median":-17.732316,"eighty":-15.847091,"marketCap":2930192911},{"date":"2025-03-28","current":-15.074845,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":3152557072},{"date":"2025-04-04","current":-10.624224,"twenty":-18.709149,"median":-17.433667,"eighty":-15.417782,"marketCap":2221812131},{"date":"2025-04-11","current":-6.570442,"twenty":-18.612493,"median":-16.926585,"eighty":-14.065167,"marketCap":1374056864},{"date":"2025-04-17","current":-8.815846,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"marketCap":1843631343}],"updateTime":1745230973551}}}